financetom
Business
financetom
/
Business
/
TPG, Transneft throw out jailed Russian mogul's $14 bln UK lawsuit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TPG, Transneft throw out jailed Russian mogul's $14 bln UK lawsuit
Jan 17, 2025 3:14 AM

LONDON, Jan 17 (Reuters) - Private equity firm TPG

and Russian state-owned firms Rosatom and Transneft

on Friday won their bid to block jailed tycoon

Ziyavudin Magomedov's $14 billion London lawsuit over an alleged

conspiracy to strip his assets.

Magomedov sued the companies and several others at London's

High Court, alleging his 2018 arrest on embezzlement charges

prompted a Russian state-supported scheme to strip him of his

holdings in valuable port operators.

The defendants all denied the allegations and last year

argued that the lawsuit should be thrown out, with TPG's lawyers

accusing Magomedov of concocting "preposterous allegations".

Judge Robert Bright ruled that the case should not continue,

saying in a written ruling that there was "no serious issue to

be tried" against TPG or Transneft and that any case against

Rosatom should be heard in Cyprus.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer Stocks Mixed Premarket Monday
Sector Update: Consumer Stocks Mixed Premarket Monday
Jun 3, 2024
09:16 AM EDT, 06/03/2024 (MT Newswires) -- Consumer stocks were mixed premarket Monday with the Consumer Staples Select Sector SPDR Fund ( XLP ) 0.2% lower and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) slightly advancing recently. GameStop ( GME ) surged past 70% after trader Keith Gill posted on his Reddit account Roaring Kitty a screenshot...
Moderna, Merck Say 3-Year Data for Melanoma Combination Therapy Show Continued Improvement in Recurrence-Free Survival
Moderna, Merck Say 3-Year Data for Melanoma Combination Therapy Show Continued Improvement in Recurrence-Free Survival
Jun 3, 2024
09:16 AM EDT, 06/03/2024 (MT Newswires) -- Moderna ( MRNA ) and Merck ( MRK ) said Monday that results from the phase 2b clinical trial assessing mRNA-4157 (V940) plus Merck's ( MRK ) Keytruda in patients with resected high-risk melanoma after complete resection showed sustained improvement in recurrence-free survival, the study's primary endpoint. The companies said that with a...
Science Applications International Optimistic About Hitting Annual Outlook Despite Q1 Revenue Dip, Shares Slide
Science Applications International Optimistic About Hitting Annual Outlook Despite Q1 Revenue Dip, Shares Slide
Jun 3, 2024
Science Applications International Corp ( SAIC ) reported a 9% revenue decline year over year in the fiscal first quarter of 2025 to $1.847 billion, marginally beating the analyst consensus estimate of $1.844 billion. Adjusted EPS of $1.92 was in line with the analyst consensus estimate. The sale of the logistics and supply chain management business and contract completions mainly led to the...
NHTSA opens probe into 74,702 Nissan Rogue vehicles
NHTSA opens probe into 74,702 Nissan Rogue vehicles
Jun 3, 2024
(Reuters) - The National Highway Traffic Safety Administration said on Monday it has opened a probe into 74,702 Nissan Rogue Select vehicles due to the inadvertent deployment of side curtain airbags. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved